|
|
Impact of Comorbidities on Stroke Outcomes and Treatments |
| RX001141-05A1 |
TOMLINSON, STEPHEN |
VA |
2023 |
|
|
Bioactive injectable implants for functional intervertebral disc regeneration |
| RX001321-06A1 |
MAUCK, ROBERT L |
VA |
2023 |
|
|
Neurophysiological Basis for Enhancing Motor Recovery After Stroke |
| RX001640-05A1 |
GANGULY, KARUNESH |
VA |
2023 |
|
|
Endoplasmic Reticulum Stress in Neurodegeneration |
| RX002340-01A1 |
LIN, JONATHAN |
VA |
2023 |
|
|
Adipose-derived stem cell-conditioned medium therapy in a mouse model of ALS |
| RX002688-01A2 |
WALKER, CHANDLER |
VA |
2023 |
|
|
Enhanced Mitochondrial Function to Increase Effectiveness of Post-Stroke Rehabilitation |
| RX003224-01 |
SCHNELLMANN, RICK G |
VA |
2023 |
|
|
Exercise and pharmacological LRRK2 inhibition for preventing PD |
| RX003253-01A2 |
DELIC, VEDAD |
VA |
2023 |
|
|
Mechano-active annular repair device for treating disc herniation |
| RX003447-01A1 |
SMITH, HARVEY E |
VA |
2023 |
|
|
Therapeutic interventions for post-stroke rehabilitation |
| RX003506-01A2 |
RAVAL, AMI P |
VA |
2023 |
|
|
Somatosensory stimulation therapies for movement disorders |
| RX003592-01 |
TAYLOR, DAWN MARIE |
VA |
2023 |
